Recruiting

Phrenic Nerve Reconstruction

Sponsor:

Advanced Reconstructive Surgery Alliance

Code:

NCT06243718

Conditions

Diaphragmatic Paralysis

Pain, Chest

Breath Shortness

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This study utilizes a grounded theory methodology to explore patient experiences of phrenic nerve reconstructive surgery as a treatment for diaphragmatic paralysis.

Conditions

Diaphragmatic Paralysis

Pain, Chest

Breath Shortness

Study ID

NCT06243718

Start date

Oct 10, 2023

Status verified date

Feb, 2024

Completion date

Oct 10, 2026

Anticipated

Primary completion date

Oct 10, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Individuals with a confirmed diagnosis of Diaphragmatic Paralysis.
  • Individuals who are scheduled to undergo phrenic nerve reconstructive surgery for the treatment of Diaphragmatic Paralysis.

Exclusion Criteria:

- Individuals who do not comprehend the English language.

Study Design

Enrollment

45 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Semi-Structured Interviews. [ Time Frame: Participants are interviewed one week before and 12 months after the surgery. ]

Central Contacts and Locations

Central contacts

Locations

Advanced Reconstructive Surgery Alliance

Recruiting

Red Bank, New Jersey, United States, 07701

Contacts

Principal Investigator:

Matthew Kaufman, MD

Institute for Advanced Reconstruction

Recruiting

Shrewsbury, New Jersey, United States, 07702

Contacts

Principal Investigator:

Matthew Kaufman, MD

More Information

Sponsor

Advanced Reconstructive Surgery Alliance

Last update posted

Feb 6, 2024

Last verified

Feb, 2024

Keywords

  • Grounded Theory
  • Diaphragmatic Paralysis
  • Diaphragm
  • Respiratory System
  • Pain

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Advanced Reconstructive Surgery Alliance on 2024-02-06.